BARBARA ANN KARMANOS CANCER INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1995-01-01

Employees: 5K

Market Cap: -

Website: http://www.karmanos.org

Clinical Trials

Medical Physics Direct Patient Care for the Improvement of Patient Understanding of Care

Not Applicable

Completed

Conditions: Malignant Neoplasm

Interventions: Other: Informational Intervention
Other: Questionnaire Administration
Other: Counseling

First Posted Date: 2020-02-12

Last Posted Date: 2022-10-07

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 45

Registration Number: NCT04266522

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 2

Terminated

Conditions: Castration Levels of Testosterone
Stage IVB Prostate Cancer AJCC v8
Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
Prostate Carcinoma Metastatic in the Bone

Interventions: Drug: Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981
Biological: Nivolumab

First Posted Date: 2019-11-12

Last Posted Date: 2024-07-16

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 10

Registration Number: NCT04159896

Locations: 🇺🇸
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer

Not Applicable

Withdrawn

Conditions: Metastatic Head and Neck Squamous Cell Carcinoma
Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions: Diagnostic Test: Monitoring Device
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2019-03-14

Last Posted Date: 2023-10-04

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Registration Number: NCT03875053

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

C.A.P.A.B.L.E. (Cross-Training and Physical Activity: A Better Life Experience Study)

Not Applicable

Recruiting

Conditions: Cancer Survivors

Interventions: Behavioral: 12 week pilot intervention study.

First Posted Date: 2018-11-23

Last Posted Date: 2024-05-21

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 100

Registration Number: NCT03750981

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Reducing Metabolic Syndrome Among Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Habit development intervention

First Posted Date: 2018-10-25

Last Posted Date: 2020-11-20

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 7

Registration Number: NCT03719677

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Music in Reducing Distress in Participants With Cancer During Chemotherapy Treatment

Not Applicable

Completed

Conditions: Caregiver
Malignant Neoplasm

Interventions: Behavioral: Music Therapy

First Posted Date: 2018-09-25

Last Posted Date: 2021-02-23

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 1000

Registration Number: NCT03683420

Locations: 🇺🇸
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

Feasibility and Utilization of an Application-based Question Prompt List

Not Applicable

Completed

Conditions: Financial Toxicity
Cancer
Question Prompt List

Interventions: Behavioral: Discussions of Cost App (DISCO App)

First Posted Date: 2018-09-19

Last Posted Date: 2024-04-18

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 35

Registration Number: NCT03676920

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Tobacco Cessation Intervention

Not Applicable

Completed

Conditions: Smoking Tobacco

Interventions: Behavioral: Educational Interventions to Promote Tobacco Cessation

First Posted Date: 2018-09-05

Last Posted Date: 2022-05-06

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 100

Registration Number: NCT03657511

Locations: 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer

Phase 2

Completed

Conditions: Castration Levels of Testosterone
Stage IV Prostate Adenocarcinoma AJCC v7
Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
PSA Progression

Interventions: Drug: ESK981

First Posted Date: 2018-03-07

Last Posted Date: 2023-07-14

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 13

Registration Number: NCT03456804

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Phase 2

Recruiting

Conditions: Carcinoid Syndrome
Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm

Interventions: Other: Carbon C 11 Alpha-methyltryptophan
Other: Laboratory Biomarker Analysis
Procedure: Positron Emission Tomography
Drug: Telotristat Etiprate

First Posted Date: 2018-03-05

Last Posted Date: 2023-05-06

Lead Sponsor: Barbara Ann Karmanos Cancer Institute

Target Recruit Count: 6

Registration Number: NCT03453489

Locations: 🇺🇸
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy